113 related articles for article (PubMed ID: 22834711)
1. Evaluation of perylenediimide derivatives for potential therapeutic benefits on cancer chemotherapy.
Keskin T; Isgor BS; Isgor YG; Yukruk F
Chem Biol Drug Des; 2012 Nov; 80(5):675-81. PubMed ID: 22834711
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors.
Li JR; Li DD; Fang F; Du QR; Lin L; Sun J; Qian Y; Zhu HL
Org Biomol Chem; 2013 Dec; 11(48):8375-86. PubMed ID: 24178241
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the human VEGF gene expression by perylene monoimide derivatives.
Taka T; Joonlasak K; Huang L; Randall Lee T; Chang SW; Tuntiwechapikul W
Bioorg Med Chem Lett; 2012 Jan; 22(1):518-22. PubMed ID: 22104143
[TBL] [Abstract][Full Text] [Related]
4. Exploration of acridine scaffold as a potentially interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase inhibitors.
Luan X; Gao C; Zhang N; Chen Y; Sun Q; Tan C; Liu H; Jin Y; Jiang Y
Bioorg Med Chem; 2011 Jun; 19(11):3312-9. PubMed ID: 21576023
[TBL] [Abstract][Full Text] [Related]
5. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of c-Src kinase inhibitory activity of pyridin-2(1H)-one derivatives.
Chand K; Prasad S; Tiwari RK; Shirazi AN; Kumar S; Parang K; Sharma SK
Bioorg Chem; 2014 Apr; 53():75-82. PubMed ID: 24632506
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase.
Huang H; Ma J; Shi J; Meng L; Jiang H; Ding J; Liu H
Bioorg Med Chem; 2010 Jul; 18(13):4615-24. PubMed ID: 20570525
[TBL] [Abstract][Full Text] [Related]
8. A facile design of thio-perylenediimides with controllable fluorescent, photodynamic and photothermal effects towards cancer theranostics.
Liu C; Ji C; Fan Z; Ma R; Yin M
Chem Commun (Camb); 2021 Dec; 57(97):13126-13129. PubMed ID: 34807201
[TBL] [Abstract][Full Text] [Related]
9. 4-Aryl-1,3,2-oxathiazolylium-5-olate: a novel GST inhibitor to release JNK and activate c-Jun for cancer therapy.
Cui H; Shen J; Lu D; Zhang T; Zhang W; Sun D; Wang PG
Cancer Chemother Pharmacol; 2008 Aug; 62(3):509-15. PubMed ID: 18008069
[TBL] [Abstract][Full Text] [Related]
10. Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activity.
Işgör YG; Kiliç Z; Olgen S
Chem Biol Drug Des; 2008 Dec; 72(6):599-604. PubMed ID: 19090928
[TBL] [Abstract][Full Text] [Related]
11. Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: dual inhibitors of EGFR and Src protein tyrosine kinases.
Lin J; Shen W; Xue J; Sun J; Zhang X; Zhang C
Eur J Med Chem; 2012 Sep; 55():39-48. PubMed ID: 22818848
[TBL] [Abstract][Full Text] [Related]
12. Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells.
Radi M; Brullo C; Crespan E; Tintori C; Musumeci F; Biava M; Schenone S; Dreassi E; Zamperini C; Maga G; Pagano D; Angelucci A; Bologna M; Botta M
Bioorg Med Chem Lett; 2011 Oct; 21(19):5928-33. PubMed ID: 21856155
[TBL] [Abstract][Full Text] [Related]
13. The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.
Cao X; You QD; Li ZY; Liu XR; Xu D; Guo QL; Shang J; Chern JW; Chen ML
Bioorg Med Chem Lett; 2008 Dec; 18(23):6206-9. PubMed ID: 18930653
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Qiu KM; Wang HH; Wang LM; Luo Y; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Mar; 20(6):2010-8. PubMed ID: 22361272
[TBL] [Abstract][Full Text] [Related]
15. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and docking studies of 4-amino-tetrahydroquinazolino[3,2-e]purine derivatives.
Verones V; Flouquet N; Farce A; Carato P; Leonce S; Pfeiffer B; Berthelot P; Lebegue N
Eur J Med Chem; 2010 Dec; 45(12):5678-84. PubMed ID: 20884092
[TBL] [Abstract][Full Text] [Related]
17. An inhibitor of glutathione S-transferase omega 1 that selectively targets apoptotic cells.
Pace NJ; Pimental DR; Weerapana E
Angew Chem Int Ed Engl; 2012 Aug; 51(33):8365-8. PubMed ID: 22777685
[No Abstract] [Full Text] [Related]
18. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA.
Gueto C; Ruiz JL; Torres JE; Méndez J; Vivas-Reyes R
Bioorg Med Chem; 2008 Mar; 16(5):2439-47. PubMed ID: 18065233
[TBL] [Abstract][Full Text] [Related]
19. SRC inhibitors as potential therapeutic agents for human cancers.
Trevino JG; Summy JM; Gallick GE
Mini Rev Med Chem; 2006 Jun; 6(6):681-7. PubMed ID: 16787379
[TBL] [Abstract][Full Text] [Related]
20. Src signaling in cancer invasion.
Guarino M
J Cell Physiol; 2010 Apr; 223(1):14-26. PubMed ID: 20049846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]